Identifying disease modifying genes in multiple sclerosis

被引:100
作者
Kantarci, OH
de Andrade, M
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
multiple sclerosis; genetics; prognosis; severity; course; outcome;
D O I
10.1016/S0165-5728(01)00481-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes, The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the cur-rent state of knowledge in this area. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:144 / 159
页数:16
相关论文
共 139 条
  • [91] New insights into the immunogenetics of multiple sclerosis
    Oksenberg, JR
    Hauser, SL
    [J]. CURRENT OPINION IN NEUROLOGY, 1997, 10 (03) : 181 - 185
  • [92] HLA CLASS-II-ASSOCIATED GENETIC SUSCEPTIBILITY IN MULTIPLE-SCLEROSIS - A CRITICAL-EVALUATION
    OLERUP, O
    HILLERT, J
    [J]. TISSUE ANTIGENS, 1991, 38 (01): : 1 - 15
  • [93] Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type)
    Ono, T
    Zambenedetti, MR
    Yamasaki, K
    Kawano, Y
    Kamikawaji, N
    Ito, H
    Sakurai, M
    Nishimura, Y
    Kira, J
    Kanazawa, I
    Sasazuki, T
    [J]. TISSUE ANTIGENS, 1998, 52 (06): : 539 - 542
  • [94] Perdriger A, 1997, J RHEUMATOL, V24, P1272
  • [95] Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis
    Pickard, C
    Mann, C
    Sinnott, P
    Boggild, M
    Hawkins, C
    Strange, RC
    Hutchinson, IV
    Ollier, WER
    Donn, RP
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (02) : 207 - 210
  • [96] NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS
    POSER, CM
    PATY, DW
    SCHEINBERG, L
    MCDONALD, WI
    DAVIS, FA
    EBERS, GC
    JOHNSON, KP
    SIBLEY, WA
    SILBERBERG, DH
    TOURTELLOTTE, WW
    [J]. ANNALS OF NEUROLOGY, 1983, 13 (03) : 227 - 231
  • [97] HLA-ANTIGENS AND THE PROGNOSIS OF MULTIPLE-SCLEROSIS
    POSER, S
    RITTER, G
    BAUER, HJ
    GROSSEWILDE, H
    KUWERT, EK
    RAUN, NE
    [J]. JOURNAL OF NEUROLOGY, 1981, 225 (03) : 219 - 221
  • [98] MULTIPLE-SCLEROSIS IN THE ORKNEY AND SHETLAND ISLANDS .3. HISTOCOMPATIBILITY DETERMINANTS
    POSKANZER, DC
    TERASAKI, PI
    PRENNEY, LB
    SHERIDAN, JL
    PARK, MS
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1980, 34 (04) : 253 - 257
  • [99] A transmission disequilibrium test for quantitative trait loci
    Rabinowitz, D
    [J]. HUMAN HEREDITY, 1997, 47 (06) : 342 - 350
  • [100] IgG allotypes and subclasses in Norwegian patients with multiple sclerosis
    Raknes, G
    Fernandes, JA
    Pandey, JP
    Myhr, KM
    Ulvestad, E
    Nyland, H
    Vedeler, CA
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 175 (02) : 111 - 115